KromaTiD appoints Christopher Tompkins new company chief executive

KromaTiD appoints Christopher Tompkins new company chief executive

LONGMONT -- KromaTiD, Inc. announced the appointment of Christopher Tompkins as CEO. Tompkins, who joined the company in 2010, most recently served as president, GM and chief technology... Read More

Wednesday June 26, 2019 0 comments Tags: Longmont, KromaTid, Christopher Tompkins

KromaTiD receives $900K in funding from Human Genome Research Institute

KromaTiD receives $900K in funding from Human Genome Research Institute

FORT COLLINS-- KromaTiD, Inc . announced that after successfully meeting Phase 1 grant milestones, the company has been awarded Phase 2 funding from a Fast Track Small Business Innovation... Read More

Wednesday April 24, 2019 0 comments Tags: Fort Collins, KromaTid, Christopher Tompkins

KromaTiD announces opening of new corporate headquarters in Longmont

KromaTiD announces opening of new corporate headquarters in Longmont

LONGMONT -- KromaTiD, Inc. today announced the opening of the companys new corporate headquarters inColorado'sBoulder Countybiotech hub. The new facility includes corporate offices as well... Read More

Thursday March 28, 2019 0 comments Tags: Longmont, KromaTid, Christopher Tompkins

KromaTID awarded Fast Track Small Business Innovation Research grant

KromaTID awarded Fast Track Small Business Innovation Research grant

FORT COLLINS -- KromaTiD, Inc . announced it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant by the National Human Genome Research Institute. The SBIR program... Read More

Wednesday August 15, 2018 0 comments Tags: Fort Collins, KromaTid, Christopher Tompkins

KromaTiD announces close of Series A fund round

KromaTiD announces close of Series A fund round

FORT COLLINS -- KromaTiD announced the successful closure of a Series A financing round. KromaTiD, provider of Directional Genomic Hybridization and Pinpoint FISH products, said it... Read More

Wednesday June 21, 2017 0 comments Tags: Fort Collins, KromaTid, Terry Opgenorth, Pinpoint FISH, Directional Genomic Hybridization, Christopher Tompkins, CSU Ventures

CBSA to hold BioBreakfast at the Capitol on Feb. 24

CBSA to hold BioBreakfast at the Capitol on Feb. 24

DENVER - Colorado BioScience Association (CBSA) will hold its annual BioBreakfast at the Capitol on Feb. 24, focusing on key 2015 legislative priorities impacting the state's 600 ... Read More

By: InnovatioNews Friday February 20, 2015 0 comments Tags: April Giles, CBSA, Christopher Tompkins, David Shine, Denver, Ginny Orndorff, Harry Horowitz

KromaTiD launches dGH line of discovery and detection tools for disease-causing mutations

KromaTiD launches dGH line of discovery and detection tools for disease-causing mutations

FORT COLLINS -- KromaTiD, Inc . has launched its directional Genomic Hybridization (dGH) line of mutation discovery and detection assays. Now available,  KromaTiD dGH products provide... Read More

By: InnovatioNews Wednesday December 11, 2013 0 comments Tags: Christopher Tompkins, dGH, Dr. Joel Bedford, Fort Collins, KromaTid

KromaTiD launches new dGH line of genetic mutation discovery tools

KromaTiD launches new dGH line of genetic mutation discovery tools

FORT COLLINS - KromaTiD Inc . today announced the launch of its directional Genomic Hybridization (dGH) line of mutation discovery and detection assays. The new products provide researchers... Read More

By: InnovatioNews Monday October 21, 2013 0 comments Tags: Christopher Tompkins, dGH, Dr. Joel Bedford, Fort Collins, KromaTid